Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02417688 · ClinicalTrials.gov registry record · Phase 1
PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis
A Phase 1 study of Carotid Atherosclerosis, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT02417688 is a Phase 1 study of Carotid Atherosclerosis that has completed, run by Washington University School of Medicine. The registered enrollment target is 44 participants, below the 164-participant average among 5 other Carotid Atherosclerosis trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02417688, a Phase 1 study of Carotid Atherosclerosis, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
To demonstrate feasibility of imaging Cu\[64\]-25%-CANF-Comb uptake in the atherosclerosis of the carotid artery of patients for whom carotid artery endarterectomy surgery is planned in comparison to the carotid artery for which intervention is not planned.
Conditions Studied
Interventions
- DEVICE Cu[64]-25%-CANF-Comb PET-MR
Study Locations (1)
Missouri
- Washington University in St.Louis - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2015-04-05 |
| Est. Completion | 2021-04-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02417688
The ClinicalTrials.gov registry entry for NCT02417688 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 164-participant average among 5 other Carotid Atherosclerosis trials with a reported enrollment target (73% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Carotid Atherosclerosis appearing as the primary indexed condition, and to 1 intervention - of which Cu[64]-25%-CANF-Comb PET-MR is the first listed.
NCT02417688 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT02417688 about?
NCT02417688 is a clinical study titled "PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis". To demonstrate feasibility of imaging Cu\[64\]-25%-CANF-Comb uptake in the atherosclerosis of the carotid artery of patients for whom carotid artery endarterectomy surgery is planned in comparison to the carotid artery for which intervention is not planned.
What is the current status of trial NCT02417688?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2015-04-05. Estimated completion is 2021-04-30.
What conditions does trial NCT02417688 study?
This clinical trial studies the following conditions: Carotid Atherosclerosis.
What interventions are being tested in trial NCT02417688?
The interventions under investigation include: Cu[64]-25%-CANF-Comb PET-MR (DEVICE).
Who is sponsoring clinical trial NCT02417688?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02417688 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carotid Atherosclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PET Detection of CCR2 in Human Atherosclerosis
RECRUITING · Phase 1
-
Potential Risk Factors for Stroke
COMPLETED · Phase 1
-
CANF-Comb-II PET-MR in Atherosclerosis Multisite
RECRUITING
-
Risk Assessment of Carotid Plaques Using 3D Contrast-Enhanced Ultrasound
ACTIVE NOT RECRUITING · Phase 4
-
Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.